Schroder Investment Management Group
GMAB icon

Schroder Investment Management Group’s Genmab GMAB Stock Holding History

Schroder Investment Management Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-242,385
Closed -$7.25M – 1230
2024
Q1 		$7.25M Buy
242,385
+115,085
+90% +$3.38M 0.01% 715
2023
Q4 		$4.05M Buy
+127,300
New +$4M 0.01% 808
2023
Q1 		– Sell
-37,579
Closed -$1.59M – 1284
2022
Q4 		$1.59M Buy
+37,579
New +$1.55M ﹤0.01% 979
2021
Q4 		– Sell
-75,150
Closed -$32.8M – 1438
2021
Q3 		$32.8M Sell
75,150
-1,202,475
-94% -$54M 0.05% 370
2021
Q2 		$52.2M Buy
1,277,625
+685,007
+116% +$26.4M 0.07% 299
2021
Q1 		$19.5M Buy
592,618
+349,810
+144% +$13.2M 0.03% 516
2020
Q4 		$9.87M Buy
+242,808
New +$9.08M 0.01% 635

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Schroder Investment Management Group's GMAB Position: Q2 2024 in Review

Schroder Investment Management Group sold out of Genmab (GMAB) in Q2 2024, closing a stake of 242,385 shares — an estimated $7.25M sold.

Schroder Investment Management Group first reported a position in GMAB in Q4 2020 and held it in 7 quarters. The position peaked at $52.2M in Q2 2021. 220 funds tracked by Wall St. Rank hold GMAB as of Q2 2024.

  • Schroder Investment Management Group reported no remaining Genmab position as of Q2 2024 after selling out during the quarter.
  • Schroder Investment Management Group sold 242,385 Genmab shares in Q2 2024, an estimated $7.25M.
  • Schroder Investment Management Group first reported a position in Genmab in Q4 2020 and held it in 7 quarters.
  • Schroder Investment Management Group's Genmab position peaked at $52.2M in Q2 2021.
  • 220 funds tracked by Wall St. Rank held Genmab as of Q2 2024.

Based on Schroder Investment Management Group's 13F filing for Q2 2024, filed 12 Aug 2024.